Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Genmab
Ocellaris Pharma, Inc.
Seagen Inc.
Fusion Pharmaceuticals Inc.
Bolt Biotherapeutics, Inc.
Pfizer
Nuvation Bio Inc.
NiKang Therapeutics, Inc.
Numab Therapeutics AG
NuCana plc
Hutchmed
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
M.D. Anderson Cancer Center
Numab Therapeutics AG
Kymab Limited
Seagen Inc.
Novartis
ADC Therapeutics S.A.
Exelixis
Ikena Oncology
Gilead Sciences
pharmaand GmbH
Atreca, Inc.
Fate Therapeutics
Genmab
Duke University
Zai Lab (Hong Kong), Ltd.
Eli Lilly and Company
Incyte Corporation
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Tocagen Inc.